Quasispecies and its impact on viral hepatitis

被引:133
作者
Domingo, Esteban [1 ]
Gomez, Jordi
机构
[1] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain
[2] CSIC, Inst Biomed & Parasitol, E-18100 Granada, Spain
关键词
HAV; HBV; HCV; HDV; interferon; lamivudine; viral load; liver damage; mutation; recombination; editing; persistence; immune escape; lethal mutagenesis; error catastrophe; HUMAN-IMMUNODEFICIENCY-VIRUS; VESICULAR STOMATITIS-VIRUS; MOUTH-DISEASE VIRUS; DYNAMICS IN-VIVO; T-CELL-EPITOPE; C VIRUS; B-VIRUS; RNA VIRUS; INTERFERON THERAPY; GENOTYPE; 1B;
D O I
10.1016/j.virusres.2007.02.001
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学];
摘要
Quasispecies dynamics mediates adaptability of RNA viruses through a number of mechanisms reviewed in the present article, with emphasis on the medical implications for the hepatitis viruses. We discuss replicative and non-replicative molecular mechanisms of genome variation, modulating effects of mutant spectra, and several modes of viral evolution that can affect viral pathogenesis. Relevant evolutionary events include the generation of minority virus variants with altered functional properties, and alterations of mutant spectrum complexity that can affect disease of progression or response to treatment. The widespread occurrence of resistance to antiviral drugs encourages new strategies to control hepatic viral disease such as combination therapies and lethal mutagenesis. In particular, ribavirin may be exerting in some cases its antiviral activity with participation of its mutagenic action. Despite many unanswered questions, here we document that quasispecies dynamics has provided an interpretation of the adaptability of the hepatitis viruses, with features conceptually similar to those observed with other RNA viruses, a reflection of the common underlying Darwinian principles. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:131 / 150
页数:20
相关论文
共 224 条
[1]
GENOMIC CHARACTERIZATION AND MUTATION-RATE OF HEPATITIS-C VIRUS ISOLATED FROM A PATIENT WHO CONTRACTED HEPATITIS DURING AN EPIDEMIC OF NON-A, NON-B HEPATITIS IN JAPAN [J].
ABE, K ;
INCHAUSPE, G ;
FUJISAWA, K .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :2725-2729
[2]
Agol VI, 2006, CURR TOP MICROBIOL, V299, P211
[3]
Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis [J].
Airaksinen, A ;
Pariente, N ;
Menéndez-Arias, L ;
Domingo, E .
VIROLOGY, 2003, 311 (02) :339-349
[4]
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine [J].
Allen, MI ;
Deslauriers, M ;
Andrews, CW ;
Tipples, GA ;
Walters, KA ;
Tyrrell, DLJ ;
Brown, N ;
Condreay, LD .
HEPATOLOGY, 1998, 27 (06) :1670-1677
[5]
Viral error catastrophe by mutagenic nucleosides [J].
Anderson, JP ;
Daifuku, R ;
Loeb, LA .
ANNUAL REVIEW OF MICROBIOLOGY, 2004, 58 :183-205
[6]
Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase [J].
Arnold, JJ ;
Vignuzzi, M ;
Stone, JK ;
Andino, R ;
Cameron, CE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (27) :25706-25716
[7]
Poliovirus RNA-dependent RNA polymerase (3Dpol) -: Divalent cation modulation of primer, template, and nucleotide selection [J].
Arnold, JJ ;
Ghosh, SKB ;
Cameron, CE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (52) :37060-37069
[8]
Mutagenic effects of ribavirin and response to interferon/ribavirin combination therapy in chronic hepatitis C [J].
Asahina, Y ;
Izumi, N ;
Enomoto, N ;
Uchihara, M ;
Kurosaki, M ;
Onuki, Y ;
Nishimura, Y ;
Ueda, K ;
Tsuchiya, K ;
Nakanishi, H ;
Kitamura, T ;
Miyake, S .
JOURNAL OF HEPATOLOGY, 2005, 43 (04) :623-629
[9]
Hepatitis B virus mutations associated with antiviral therapy [J].
Bartholomeusz, A. ;
Locarnini, S. .
JOURNAL OF MEDICAL VIROLOGY, 2006, 78 :S52-S55
[10]
Antiviral drug resistance: Clinical consequences and molecular aspects [J].
Bartholorneusz, A ;
Locarnini, SA .
SEMINARS IN LIVER DISEASE, 2006, 26 (02) :162-170